MEK guards proteome stability and inhibits tumor-suppressive amyloidogenesis via HSF1

Zijian Tang1, Siyuan Dai2, Yishu He2

  • 1The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609, USA; Graduate Programs, Department of Molecular and Biomedical Sciences, The University of Maine, 5735 Hitchner Hall, Orono, ME 04469, USA.

Cell
|February 14, 2015
PubMed

Insights

The RAS/MAP kinase pathway

Area of Science:

  • Cellular Biology
  • Oncology
  • Proteostasis

Background:

  • The RAS/MAP kinase pathway is crucial in cell signaling.
  • ERK was previously considered the sole MEK substrate.
  • The role of MEK in regulating the proteotoxic stress response was unclear.

Purpose of the Study:

  • To identify novel MEK substrates.
  • To investigate the role of MEK-HSF1 signaling in cancer.
  • To explore therapeutic strategies targeting tumor proteostasis.

Main Methods:

  • Investigated MEK-HSF1 interaction and regulation.
  • Analyzed proteomic changes in tumor cells upon MEK blockade.
  • Assessed the impact of amyloidogenesis on tumor growth in vivo.

Main Results:

  • HSF1 identified as a novel MEK substrate.
  • MEK blockade in tumor cells causes proteomic chaos and amyloidogenesis.
  • Tumor cells exhibit heightened susceptibility to proteomic perturbation.
  • Amyloidogenesis demonstrates tumor-suppressive effects, inhibiting melanoma growth.

Conclusions:

  • Oncogenic RAS-MEK signaling maintains proteostasis and suppresses amyloidogenesis.
  • Proteomic instability is inherent to the malignant state.
  • Targeting tumor proteostasis to induce amyloidogenesis is a potential anti-cancer strategy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.3K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
10.0K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.6K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
2.0K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.7K